[HTML][HTML] Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants

S Bhagchandani, JA Johnson, DJ Irvine - Advanced drug delivery reviews, 2021 - Elsevier
Imidazoquinoline derivatives (IMDs) and related compounds function as synthetic agonists
of Toll-like receptors 7 and 8 (TLR7/8) and one is FDA approved for topical antiviral and skin …

Liposome and immune system interplay: Challenges and potentials

F Zahednezhad, M Saadat, H Valizadeh… - Journal of Controlled …, 2019 - Elsevier
Liposome as a revolutionizing carrier, has exhibited favorable aspects in drug delivery.
However, there are numerous challenges affecting its effectiveness. Hypersensitivity …

Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines

LO De Serrano, DJ Burkhart - Journal of nanobiotechnology, 2017 - Springer
Vaccinology is one of the most important cornerstones in modern medicine, providing better
quality of life. The human immune system is composed of innate and adaptive immune …

Mechanisms of selective monocyte targeting by liposomes functionalized with a cationic, arginine-rich lipopeptide

R Münter, M Bak, E Christensen, PJ Kempen… - Acta Biomaterialia, 2022 - Elsevier
Stimulation of monocytes with immunomodulating agents can harness the immune system to
treat a long range of diseases, including cancers, infections and autoimmune diseases. To …

[HTML][HTML] Liposomes-Human phagocytes interplay in whole blood: effect of liposome design

M Giambelluca, E Markova, C Louet, B Steinkjer… - … , Biology and Medicine, 2023 - Elsevier
Nanomedicine holds immense potential for therapeutic manipulation of phagocytic immune
cells. However, in vitro studies often fail to accurately translate to the complex in vivo …

Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klauber, JM Laursen, D Zucker, S Brix, SS Jensen… - Acta Biomaterialia, 2017 - Elsevier
Tumor immune escape is today recognized as an important cancer hallmark and is therefore
a major focus area in cancer therapy. Monocytes and dendritic cells (DCs), which are central …

[HTML][HTML] Deciphering the monocyte-targeting mechanisms of PEGylated cationic liposomes by investigating the biomolecular corona

R Münter, M Bak, ME Thomsen, L Parhamifar… - International Journal of …, 2024 - Elsevier
Cationic liposomes specifically target monocytes in blood, rendering them promising drug-
delivery tools for cancer immunotherapy, vaccines, and therapies for monocytic leukaemia …

Receptor agonist/antagonist-incorporated anticancer nanodrugs: Design, materials, and strategies

SJ Hao, SY Wu, YK Chang, FG Wu - Materials Today, 2024 - Elsevier
With the continuous discovery of receptors that are closely involved in tumor occurrence and
progression, modulating the activity of these receptors to achieve tumor therapy via their …

Lipidic aminoglycoside derivatives: a new class of immunomodulators inducing a potent innate immune stimulation

T Colombani, T Haudebourg, M Decossas… - Advanced …, 2019 - Wiley Online Library
Abstract Development of simple and fully characterized immunomodulatory molecules is an
active area of research to enhance current immunotherapies. Monophosphoryl lipid A …

Targeting strategies of liposomal subunit vaccine delivery systems to improve vaccine efficacy

R Yu, Y Mai, Y Zhao, Y Hou, Y Liu… - Journal of drug targeting, 2019 - Taylor & Francis
Liposomes are versatile delivery systems and immunological adjuvants that not only can
load various antigens, such as proteins, peptides, nucleic acids and carbohydrates, but also …